Voyager Therapeutics (VYGR) Asset Utilization Ratio (2015 - 2026)
Voyager Therapeutics (VYGR) posted Asset Utilization Ratio of 0.15 for Q1 2026, up 3.62% sequentially from 0.15 in Q4 2025, and down 13.69% YoY from 0.18 in Q1 2025.
Voyager Therapeutics (VYGR) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Voyager Therapeutics has reported Asset Utilization Ratio for 12 years, with the latest figure at 0.15 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 13.69% year-over-year to 0.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.15 (down 13.69% YoY) and the FY2025 annual result came in at 0.13, down 41.79% from the prior year.
- Asset Utilization Ratio grew to 0.15 in Q1 2026 per VYGR's latest filing, from 0.15 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.77 in Q4 2023 and troughed at 0.1 in Q3 2025.
- A 5-year average of 0.32 and a median of 0.24 in 2022 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio plunged 76.37% in 2022, then soared 409.54% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.24 in 2022, then soared by 223.56% to 0.77 in 2023, then tumbled by 74.77% to 0.2 in 2024, then decreased by 23.47% to 0.15 in 2025, then climbed by 3.62% to 0.15 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.15, 0.15, and 0.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 0.13 |
| 10 | Voyager Therapeutics | 205.34 Mn | 89.00 Mn | - | 0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.17 |
| Mar 31, 2026 | 0.15 |
| Dec 31, 2025 | 0.15 |
| Sep 30, 2025 | 0.10 |
| Jun 30, 2025 | 0.13 |
| Mar 31, 2025 | 0.18 |
| Dec 31, 2024 | 0.20 |
| Sep 30, 2024 | 0.38 |
| Jun 30, 2024 | 0.32 |
| Mar 31, 2024 | 0.29 |
| Dec 31, 2023 | 0.77 |
| Sep 30, 2023 | 0.52 |
| Jun 30, 2023 | 0.60 |
| Mar 31, 2023 | 0.77 |
| Dec 31, 2022 | 0.24 |
| Sep 30, 2022 | 0.38 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.15 |
| Dec 31, 2021 | 0.20 |
| Sep 30, 2021 | 0.08 |